Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lineage Therap ( (LCTX) ) has shared an update.
Lineage Cell Therapeutics has announced a registered direct offering to raise up to $66 million, involving healthcare-focused institutional investors and Broadwood Partners. The deal includes the sale of over 39 million common shares and warrants, with a potential additional $36 million from warrant exercises. The proceeds aim to support working capital and R&D. H.C. Wainwright & Co. is the exclusive placement agent for the offering, anticipated to close pending customary conditions and shareholder approval.
For an in-depth examination of LCTX stock, go to TipRanks’ Stock Analysis page.
